Latin America Advanced Wound Care Market is expected to grow with the CAGR of 3.50% in the forecast period of 2020 to 2027. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/latin-america-advanced-wound-care-market

Latin America advanced wound care market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.   

The major players dealing in advanced wound care market are introducing strong range of products. For instance, In June 2018, 3M has introduced the product Elastic Blend Nonwoven Tape.  The product has various properties such as water-resistant tape along with the excellent initial skin adhesion property. The product is a pressure sensitive adhesive offers the Improved Conformability and Skin Breathability. This will help in expansion of product portfolio of the company.

Mölnlycke Healthcare AB is the dominating player in advanced wound care market. The other key players existing in the market includes Smith and Nephew, BSN medical (A subsidiary of Essity AB), PAUL HARTMANN Chile SpA, Cardinal Health, 3M, Acell INC., B. Braun Melsungen AG, ConvaTec Group PLC, Coloplast Group, and Johnson & Johnson Services, among others.  

Mölnlycke Health Care AB

Mölnlycke Health Care AB, headquartered in Gothenburg, Sweden, which was founded in 1849. The company provides medical products and solutions for healthcare industry related to wound management, surgery and pressure ulcer prevention. Company also has wide product portfolio mepilex transfer, mepilex border, mepilex border sacrum, mepilex ag, exufiber ag+, exufiber, mepilex border post-op, mepiform, mepilex border flex, in this mepilex transfer, mepilex border, mepilex border sacrum, mepilex Ag, Exufiber Ag+, exufiber, mepilex border post-Op, mepiform, mepilex border flex are the market focused category.  

• In January 2019, Mölnlycke Health Care AB has announced the acquisition of the M&J Airlaid products. M&J Airlaid is the key manufacturer of the absorbent airlaid nonwoven wound care materials. Because of the high revenue, the company supports the Mölnlycke in R & D investments and growth. Moreover it is further strengthening its wound care capabilities and product portfolio in the market.

The company has presence in Asia-Pacific, North America, Europe, South America, Middle East and Africa.

Smith & Nephew

Smith & Nephew is headquartered in London, U.K. was founded in 1856. The company focuses towards designing, developing and selling medical devices. The company has multiple business segments orthopaedics, sports medicine & ENT and advanced wound management, in these advanced wound management is the market focused segment. Company also has wide product portfolio in orthopaedics, sports medicine & ENT and advanced wound management, in this advanced wound management is the market focused product category.

• In April, Smith & Nephew has acquired the company Leaf Healthcare, Inc. which is a manufacturer of unique pressure injury prevention device. This helps in expansion as well as makes the company’s product portfolio strong.

The company has global presence in Asia-Pacific, North America, Europe, South America, Middle East and Africa. The company also has various subsidiary companies such as Blue Belt Technologies UK Limited (U.K.), Neotherix Limited (U.S.), Plus Orthopedics (U.K.) Limited (U.K.), Arthrocare Corporation (U.S.), Bioventus LLC (U.S.), Smith & Nephew Pty Limited (Australia), ArthoCare Medical Devices (Beijing) Co. Limited (China) among others.

BSN medical (A Subsidiary of Essity AB)

BSN medical (A Subsidiary of Essity AB) is headquartered in Hamburg, Germany which was founded in 2001. The company mainly engaged in the production and trading of wound care and related vascular diseases along with the lymphology and non-invasive orthopaedic products. Company also has wide product portfolio in wound & vascular treatment, orthopedics, in this wound & vascular treatment is the market focused product category.

• In April 2016, BSN Medical launched three new integrated therapeutic solutions used on the treatment of diabetic foot ulcers (DFUs), venous leg ulcers (VLUs) and postoperative surgical sites. Furthermore, these solutions support the launch of two new wound care products, plus the company's DACC technology, which is a powerful alternative of the silver antimicrobial dressing, and products featuring the JOBST brand compression therapy. With these products Launches Company will able to strengthening of their market presence in advanced wound care market.

The company has global presence in North America, Europe, South America, Middle East and Africa, Latin America, Asia Pacific.